$IOVA We got endometrial, melonona, soft tissue cancer updates. AND LUNG data that they seem to love ANNND we still have 4001 AND 5001!
What they’re saying is, “I’m standing in front of a burning house, and I’m offering you fire insurance on it!”
Yeah 9 is cheap…and so is 20.
$AQST one of the most bullish CC from the team. They are setting themselves up for highest possible BO. Most people focus on 109 but 108 has potential to be right up there with it and let’s not forget libervant and the many drugs it has/CAN have when their technology is acquired.
@impulsefinancfo@BIOTECHSCANNER Not necessarily. The one thing people say could be a knock is their cash position (even though they have stated it is a non issue) with libervant being approved there is absolutely nothing anyone can say and it’s rockets